Rapid Micro Biosystems (RPID) Gross Profit Growth (3y) (2023 - 2026)

Rapid Micro Biosystems (RPID) Gross Profit Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Profit Growth (3y) (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 5.02%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 8.10%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 4.54%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 15.44%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 9.03%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.15%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 17.49%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 1.49%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 8.46%
10 Rapid Micro Biosystems 77.24 Mn 54.29 Mn 371,000.00 -38.22%

Historic Data

Download Data
DateValue
Mar 31, 2026 -38.22%
Dec 31, 2025 216.95%
Sep 30, 2025 82.82%
Jun 30, 2025 122.61%
Mar 31, 2025 -16.90%
Dec 31, 2024 41.38%
Sep 30, 2024 3.30%
Jun 30, 2024 -0.19%
Mar 31, 2024 -5.03%
Dec 31, 2023 -2.48%
Sep 30, 2023 -11.35%
Jun 30, 2023 9.90%